Basics Amarin Corporation plc Amarin Corp PLC is a biopharmaceutical company with expertise in lipid science. The company is engaged in commercialization and development of therapeutics to improve cardiovascular health. IPO Date: April 1, 1993 Sector: Healthcare Industry: Biotech Market Cap: $317.07M Activated in VL: True Average Daily Range Avg Daily Range: $0.15 | 3.50% Avg Daily Range (30 D): $0.23 | 1.52% Avg Daily Range (90 D): $0.28 | 2.08% Institutional Daily Volume Avg Daily Volume: 2.75M Avg Daily Volume (30 D): .05M Avg Daily Volume (90 D): .09M Trade Size Avg Trade Size (Sh.): 303 Avg Trade Size (Sh.) (30 D): 75 Avg Trade Size (Sh.) (90 D): 85 Institutional Trades Total Inst.Trades: 4,734 Avg Inst. Trade: $1.26M Avg Inst. Trade (30 D): $1.38M Avg Inst. Trade (90 D): $1.38M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $1.48M Avg Closing Trade (30 D): $.8M Avg Closing Trade (90 D): $.8M Avg Closing Volume: 6.65K     News Mar 12, 2025 @ 11:01 AM Amarin Announces Plan to Initiate a Ratio Change U... Source: Amarin Corporation Plc Dec 13, 2024 @ 2:00 PM Amarin Appoints Peter Fishman Chief Financial Offi... Source: N/A Jun 4, 2024 @ 11:30 AM Amarin Board of Directors Announces CEO Transition... Source: Amarin Corporation plc May 28, 2024 @ 12:15 PM  Amarin Receives National Reimbursement for VAZ... Source: Amarin Corporation plc May 6, 2024 @ 12:00 PM Amarin to Present at H.C. Wainwright 2nd Annual Bi... Source: Amarin Corporation plc Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.25 $-.03 $-.04 Diluted EPS $-.25 $-.03 $-.04 Revenue $ 219.36M $ 72.74M $ 42.02M Gross Profit $ 82.2M $ 50.36M $ 25.13M Net Income / Loss $ -103.59M $ -14.14M $ -15.7M Operating Income / Loss $ -110.43M $ -15.99M $ -16.76M Cost of Revenue $ 137.16M $ 22.38M $ 16.89M Net Cash Flow $ -68.27M $ 28.35M $ -1.51M PE Ratio     Splits Apr 11, 2025:   1:20 Jan 18, 2008:   1:10